Skip to main content

Compare Stocks

Date Range: 

 StarpharmaLuna InnovationsAnavex Life SciencesBioanalytical SystemsAuxly Cannabis Group
SymbolOTCMKTS:SPHRYNASDAQ:LUNANASDAQ:AVXLNASDAQ:BASIOTCMKTS:CBWTF
Price Information
Current Price$12.90$11.23$10.16$22.69$0.28
52 Week RangeN/ABuyBuyBuyBuy
MarketRank™
Overall Score0.51.51.31.21.4
Analysis Score0.03.53.51.53.5
Community Score2.32.53.02.33.0
Dividend Score0.00.00.00.00.0
Ownership Score0.00.80.01.70.0
Earnings & Valuation Score0.00.60.00.60.6
Analyst Ratings
Consensus RecommendationN/ABuyBuyBuyBuy
Consensus Price TargetN/A$14.50$17.60$17.00$0.40
% Upside from Price TargetN/A29.12% upside73.23% upside-25.08% downside43.37% upside
Trade Information
Market Cap$523.84 million$352.60 million$711.52 million$252.56 million$209.17 million
Beta1.861.230.71.920.61
Average Volume3,417204,9023,051,952122,9251,935,648
Sales & Book Value
Annual Revenue$4.40 million$70.52 millionN/A$60.47 million$6.29 million
Price / Sales119.065.00N/A4.1833.25
CashflowN/A$0.31 per shareN/A$0.04 per shareN/A
Price / CashN/A36.78N/A558.40N/A
Book Value$0.56 per share$2.40 per share$0.45 per share$0.69 per share$0.31 per share
Price / Book23.044.68N/A32.880.90
Profitability
Net Income$-9,860,000.00$5.34 million$-26,280,000.00$-4,680,000.00$-77,300,000.00
EPSN/A$0.17($0.45)($0.35)N/A
Trailing P/E Ratio0.0062.39N/AN/AN/A
Forward P/E Ratio∞43.19N/A567.25∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A7.21%N/A-7.75%-332.96%
Return on Equity (ROE)N/A10.72%-102.39%-42.74%-47.37%
Return on Assets (ROA)N/A8.32%-81.73%-6.38%-28.34%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.03%N/AN/A2.49%0.53%
Current Ratio5.48%4.37%4.73%0.48%1.82%
Quick Ratio5.40%3.57%4.73%0.46%0.91%
Ownership Information
Institutional Ownership PercentageN/A42.38%18.92%10.62%0.01%
Insider Ownership PercentageN/A11.20%12.40%11.46%N/A
Miscellaneous
EmployeesN/A41120397431
Shares Outstanding40.61 million31.40 million70.03 million11.13 million749.71 million
Next Earnings DateN/A5/17/2021 (Confirmed)N/AN/A6/7/2021 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable
SourceHeadline
Auxly Announces $8.0 Million Private PlacementAuxly Announces $8.0 Million Private Placement
finance.yahoo.com - May 13 at 11:51 AM
Auxly Cannabis hires first chief people officerAuxly Cannabis hires first chief people officer
hcamag.com - May 5 at 11:49 AM
Auxly Cannabis Group (OTCMKTS:CBWTF) Shares Down 2.1% Auxly Cannabis Group (OTCMKTS:CBWTF) Shares Down 2.1%
americanbankingnews.com - April 27 at 12:46 AM
Auxly Q4 Net Cannabis Revenue Increases 40% Sequentially to $18.3 MillionAuxly Q4 Net Cannabis Revenue Increases 40% Sequentially to $18.3 Million
newcannabisventures.com - April 26 at 12:49 PM
Auxly Cannabis Group Inc. (CBWTF:CA)Auxly Cannabis Group Inc. (CBWTF:CA)
nasdaq.com - April 23 at 2:24 PM
Auxly Cannabis Group Inc (XLY)Auxly Cannabis Group Inc (XLY)
investing.com - April 18 at 9:11 PM
Auxly Receives Approval to Begin Trading on the Toronto Stock Exchange April 20, 2021Auxly Receives Approval to Begin Trading on the Toronto Stock Exchange April 20, 2021
finance.yahoo.com - April 16 at 8:05 PM
Auxly To Graduate To The Toronto Stock Exchange (TSX)Auxly To Graduate To The Toronto Stock Exchange (TSX)
feeds.benzinga.com - March 29 at 2:50 PM
Auxly Receives Conditional Approval to Graduate to the Toronto Stock ExchangeAuxly Receives Conditional Approval to Graduate to the Toronto Stock Exchange
finance.yahoo.com - March 29 at 8:48 AM
Embrace the Unexpected: Kolab Project Launches First Cannabis Concentrate with 232 Series DiamondsEmbrace the Unexpected: Kolab Project Launches First Cannabis Concentrate with 232 Series Diamonds
finance.yahoo.com - March 24 at 8:22 AM
Auxly Announces At-The-Market Equity ProgramAuxly Announces At-The-Market Equity Program
finance.yahoo.com - March 23 at 10:15 AM
Auxly: 2020 Was A Milestone, But It Came At Great CostsAuxly: 2020 Was A Milestone, But It Came At Great Costs
seekingalpha.com - February 28 at 12:46 PM
Auxly Announces $15 Million Bought-Deal Public OfferingAuxly Announces $15 Million Bought-Deal Public Offering
finance.yahoo.com - January 20 at 8:40 PM
Kolab Project Launches 232 Series Limited Edition Live Terpene 510 Vape CartridgesKolab Project Launches 232 Series Limited Edition Live Terpene 510 Vape Cartridges
finance.yahoo.com - December 17 at 7:43 AM
Auxly Announces Closing of $13.8 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment OptionAuxly Announces Closing of $13.8 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option
finance.yahoo.com - December 15 at 12:35 PM
MFDA announces disciplinary proceeding in respect of Michael FarrellMFDA announces disciplinary proceeding in respect of Michael Farrell
finance.yahoo.com - December 7 at 5:55 PM
Auxly Reports Third Quarter 2020 Financial ResultsAuxly Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 30 at 2:19 PM
Auxly Secures $12M In FinancingAuxly Secures $12M In Financing
feeds.benzinga.com - November 24 at 2:25 PM
Auxly Announces Upsized Bought-Deal Public Offering to $12 MillionAuxly Announces Upsized Bought-Deal Public Offering to $12 Million
benzinga.com - November 24 at 2:05 PM
Auxly Announces $10 Million Bought-Deal Public OfferingAuxly Announces $10 Million Bought-Deal Public Offering
finance.yahoo.com - November 24 at 9:04 AM
High-Potency, Plant-Based Wellness: Dosecann Introduces Cannabis Capsules With Omega-Rich Ahiflower® Oil, A Truly Differentiated Product for the Wellness ConsumerHigh-Potency, Plant-Based Wellness: Dosecann Introduces Cannabis Capsules With Omega-Rich Ahiflower® Oil, A Truly Differentiated Product for the Wellness Consumer
finance.yahoo.com - November 23 at 7:59 AM
Auxly Cannabis Group Inc. CBWTFAuxly Cannabis Group Inc. CBWTF
stockhouse.com - October 28 at 5:02 PM
Auxly’s Subsidiary KGK Science Receives Research Licence to Conduct Product Palatability and Sensory Testing with Human SubjectsAuxly’s Subsidiary KGK Science Receives Research Licence to Conduct Product Palatability and Sensory Testing with Human Subjects
finance.yahoo.com - September 22 at 8:38 AM
Auxly Files Early Warning ReportAuxly Files Early Warning Report
financialpost.com - September 18 at 7:41 AM
High-Quality Cannabis, Grown with Passion: Introducing Kolab Project Flower – a New Dried-Flower Collaboration Between Kolab Project and Craft Growers Lotus Cannabis Co., Available NowHigh-Quality Cannabis, Grown with Passion: Introducing Kolab Project Flower – a New Dried-Flower Collaboration Between Kolab Project and Craft Growers Lotus Cannabis Co., Available Now
finance.yahoo.com - September 2 at 9:45 AM
DateCompanyBrokerageAction
1/16/2019StarpharmaMacquarieInitiated Coverage
3/12/2021Luna InnovationsB. RileyBoost Price Target
3/6/2020Luna InnovationsNorthland SecuritiesDowngrade
10/2/2018Luna InnovationsDawson JamesInitiated Coverage
3/1/2021Anavex Life SciencesCantor FitzgeraldReiterated Rating
2/17/2021Anavex Life SciencesLADENBURG THALM/SH SHReiterated Rating
12/16/2020Anavex Life SciencesHC WainwrightBoost Price Target
6/8/2020Anavex Life SciencesJanney Montgomery ScottReiterated Rating
5/23/2019Anavex Life SciencesRoth CapitalReiterated Rating
12/13/2018Anavex Life SciencesMaxim GroupSet Price Target
3/9/2021Bioanalytical SystemsColliers SecuritiesReiterated Rating
9/1/2020Auxly Cannabis GroupRaymond JamesReiterated Rating
7/16/2020Auxly Cannabis GroupDesjardinsInitiated Coverage
(Data available from 5/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
Comparison Ideas:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.